Published in Mod Pathol on June 01, 2007
Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat (2010) 2.49
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst (2008) 2.24
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res (2010) 1.48
Relevance of PTEN loss in brain metastasis formation in breast cancer patients. Breast Cancer Res (2012) 1.20
Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer. Mol Cancer Res (2011) 1.18
Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol (2009) 1.06
αB-crystallin: a novel regulator of breast cancer metastasis to the brain. Clin Cancer Res (2013) 1.02
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nat Clin Pract Oncol (2008) 0.99
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. Breast Cancer Res (2012) 0.95
SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling. Mol Cell Biol (2013) 0.93
TMPRSS4 as a poor prognostic factor for triple-negative breast cancer. Int J Mol Sci (2013) 0.92
Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res (2016) 0.92
A subset of breast cancer predisposes to brain metastasis. Med Mol Morphol (2011) 0.91
GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2). J Biol Chem (2014) 0.90
Circulating Tumor Cells Detected by RT-PCR for CK-20 before Surgery Indicate Worse Prognostic Impact in Triple-Negative and HER2 Subtype Breast Cancer. J Breast Cancer (2012) 0.82
[Beyond staging, typing and grading. New challenges in breast cancer pathology]. Pathologe (2010) 0.80
Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases. Neuro Oncol (2015) 0.80
Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Breast Care (Basel) (2010) 0.80
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS One (2015) 0.80
High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med (2014) 0.80
Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma. Appl Immunohistochem Mol Morphol (2014) 0.80
Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastases. Int J Breast Cancer (2012) 0.80
Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes. Br J Cancer (2016) 0.80
EGFR and HER2 signaling in breast cancer brain metastasis. Front Biosci (Elite Ed) (2016) 0.79
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget (2015) 0.79
Molecular aspects of breast cancer metastasis to the brain. Genet Res Int (2011) 0.79
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer. Int J Clin Exp Pathol (2014) 0.78
Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases. PLoS One (2012) 0.78
Antiangiogenesis immunotherapy induces epitope spreading to Her-2/neu resulting in breast tumor immunoediting. Breast Cancer (Dove Med Press) (2009) 0.78
Expression of Yes-associated protein (YAP) in metastatic breast cancer. Int J Clin Exp Pathol (2015) 0.78
Gene Expression Profiling of Breast Cancer Brain Metastasis. Sci Rep (2016) 0.78
Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med (2014) 0.77
Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. J Transl Med (2015) 0.77
CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary. J Cancer Res Clin Oncol (2012) 0.76
Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer. J Cancer Res Clin Oncol (2013) 0.76
Detecting Tumor Metastases: The Road to Therapy Starts Here. Adv Cancer Res (2016) 0.75
αB-crystallin Expression in Breast Cancer is Associated with Brain Metastasis. NPJ Breast Cancer (2015) 0.75
Expression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site. Int J Clin Exp Pathol (2014) 0.75
Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases. Dis Markers (2017) 0.75
A triple negative breast cancer: what it is not! Breast Cancer (Dove Med Press) (2012) 0.75
[Translational research and diagnostics for breast cancer]. Pathologe (2012) 0.75
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology (2008) 2.56
The phenotype of human STK4 deficiency. Blood (2012) 1.84
Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol (2002) 1.71
Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant (2005) 1.54
The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest. Eur J Cardiothorac Surg (2011) 1.51
Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor. Clin Infect Dis (2013) 1.48
Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer (2010) 1.47
Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury. Gastroenterology (2008) 1.46
EGFR mutation detection in NSCLC--assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch (2010) 1.45
ADAMTS13--marker of contractile phenotype of arterial smooth muscle cells lost in benign nephrosclerosis. Nephrol Dial Transplant (2010) 1.44
Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection? Eur J Cardiothorac Surg (2006) 1.44
Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2010) 1.43
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res (2004) 1.42
Uncommon primary mediastinal tumours. Lancet Oncol (2004) 1.41
Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma. Histopathology (2009) 1.41
Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology (2002) 1.38
Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology (2012) 1.37
A critical role for notch signaling in the formation of cholangiocellular carcinomas. Cancer Cell (2013) 1.30
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene (2003) 1.27
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma. Immunology (2009) 1.25
Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem (2007) 1.25
Guideline on the requirements of external quality assessment programs in molecular pathology. Virchows Arch (2012) 1.24
Chordomas of the skull base: surgical management and outcome. J Neurosurg (2007) 1.21
Rapid and large-scale transition of new tumor biomarkers to clinical biopsy material by innovative tissue microarray systems. Appl Immunohistochem Mol Morphol (2003) 1.19
Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts. J Surg Res (2007) 1.18
Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care (2009) 1.16
Legumain expression as a prognostic factor in breast cancer patients. Breast Cancer Res Treat (2006) 1.16
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep (2005) 1.16
RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol Cell (2011) 1.16
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology (2007) 1.15
Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat (2006) 1.15
High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res (2006) 1.13
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Proc Natl Acad Sci U S A (2006) 1.12
Benign cystic mesothelioma of the liver. Am J Surg Pathol (2002) 1.11
Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. J Hepatol (2008) 1.10
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. J Clin Invest (2010) 1.07
Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma. Hepatology (2013) 1.07
Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg (2009) 1.06
IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Arch (2003) 1.06
PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem (2008) 1.04
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation. Haematologica (2009) 1.01
Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix. J Thorac Cardiovasc Surg (2009) 1.01
Rise and fall of an anti-MUC1 specific antibody. PLoS One (2011) 0.99
Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med (2006) 0.99
Angioimmunoblastic T-cell lymphoma. Crit Rev Oncol Hematol (2008) 0.99
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation (2004) 0.99
Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology (2005) 0.98
Feasibility study for secure closure of natural orifice transluminal endoscopic surgery gastrotomies by using over-the-scope clips. Gastrointest Endosc (2008) 0.98
Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. J Pathol (2005) 0.97
Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma. Mod Pathol (2008) 0.96
Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am J Pathol (2005) 0.96
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression. Cancer (2005) 0.96
Gene expression profile of the infective murine model for biliary atresia. Pediatr Surg Int (2006) 0.94
Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses. Cancer Res (2006) 0.93
Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin Gastroenterol Hepatol (2006) 0.93
Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer. Int J Cancer (2010) 0.92
Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol (2007) 0.92
Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. Mod Pathol (2008) 0.92
Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med (2012) 0.92
BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib. Cancer Genet Cytogenet (2005) 0.90
Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results. World J Urol (2003) 0.90
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study. Ann Hematol (2005) 0.90
Proliferation potential of spinal meningiomas. Eur Spine J (2005) 0.89
Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells. Int J Oncol (2012) 0.89
Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique. Virchows Arch (2004) 0.88
Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol (2011) 0.88
Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages. Blood (2003) 0.88
Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background. Int J Exp Pathol (2007) 0.88
Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases. Virchows Arch (2011) 0.87
Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia. Ann Hematol (2010) 0.87
Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation (2003) 0.87
Bilateral fibular graft: biological reconstruction after resection of primary malignant bone tumors of the lower limb. Sarcoma (2013) 0.86
Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis. Haematologica (2005) 0.86
Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer. Breast J (2005) 0.86
Expression of hepatocyte growth factor and c-MET in skull base chordoma. Cancer (2008) 0.85
Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma. Am J Clin Pathol (2004) 0.85
SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas. Pathol Res Pract (2005) 0.85
CO(2) pneumoperitoneum increases systemic but not local tumor spread after intraperitoneal murine neuroblastoma spillage in mice. Surg Endosc (2008) 0.84
Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet (2009) 0.84
High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood (2008) 0.84
Retracted Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer. J Clin Endocrinol Metab (2005) 0.83
Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo. PLoS One (2013) 0.83
Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display. World J Surg (2005) 0.83
Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression. Blood (2002) 0.83
Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2009) 0.83
Everolimus interferes with the inflammatory phase of healing in experimental colonic anastomoses. J Surg Res (2009) 0.82
Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients. Anticancer Res (2014) 0.82
Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma. Eur Spine J (2014) 0.81
p16INK4a expression and clinicopathologic parameters in renal cell carcinoma. Eur Urol (2006) 0.81
Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J Surg Res (2005) 0.81
Comparison of different tissue sampling methods for protein extraction from formalin-fixed and paraffin-embedded tissue specimens. Exp Mol Pathol (2009) 0.81
RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas? Surgery (2003) 0.81
Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis. Nephron Extra (2013) 0.80
Nephroblastomatosis and loss of WT1 expression associated with trisomy 13. Virchows Arch (2005) 0.80